Cardiex unveils CONNEQT pulse monitor and app in US

Grafa01-23

CardieX (ASX:CDX) has launched its CONNEQT Pulse and CONNEQT App in the United States.

The Pulse, touted as the world’s most advanced personal arterial health monitor, has begun delivery to US customers with the initial shipment of 3,000 units received from manufacturing partner, Andon.

An additional 5,000 units are en route to the company's fulfilment facility.

The company is implementing its sales strategy, focusing on converting waitlist customers through various online marketing initiatives.

The broader US market launch aims to expand the company’s presence.

In conjunction with the Pulse, the CONNEQT App is now available for download on both the App Store and Google Play Store.

The app provides features such as a digital health coach, comprehensive arterial health metrics, guided health programs, educational health content, and more.

Cardiex CEO Craig Cooper stated, "We’re off to a great start in 2025 with the launch of Pulse deliveries and the introduction of the CONNEQT App across the mobile ecosystem."

CardieX is a digital health technology company that develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. It specialises in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders.

At the time of reporting, CardieX's share price was $0.14.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment